SALA, GESSICA
 Distribuzione geografica
Continente #
NA - Nord America 11.256
AS - Asia 6.006
EU - Europa 5.787
SA - Sud America 875
AF - Africa 151
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 10
Totale 24.097
Nazione #
US - Stati Uniti d'America 10.693
SG - Singapore 1.982
IT - Italia 1.589
CN - Cina 1.377
VN - Vietnam 924
DE - Germania 820
RU - Federazione Russa 712
BR - Brasile 666
HK - Hong Kong 658
SE - Svezia 612
CA - Canada 456
IE - Irlanda 400
GB - Regno Unito 362
UA - Ucraina 317
IN - India 254
FR - Francia 215
FI - Finlandia 176
AT - Austria 148
KR - Corea 110
BD - Bangladesh 108
PL - Polonia 89
TR - Turchia 83
NL - Olanda 77
AR - Argentina 75
IQ - Iraq 71
ES - Italia 70
ID - Indonesia 68
MX - Messico 63
JP - Giappone 62
PK - Pakistan 57
DK - Danimarca 49
PH - Filippine 46
BE - Belgio 43
ZA - Sudafrica 40
IR - Iran 39
EC - Ecuador 29
CO - Colombia 28
EG - Egitto 25
SA - Arabia Saudita 25
VE - Venezuela 24
CH - Svizzera 22
UZ - Uzbekistan 21
KE - Kenya 19
ET - Etiopia 16
PY - Paraguay 16
MA - Marocco 15
MY - Malesia 15
JM - Giamaica 14
LT - Lituania 14
CL - Cile 13
AE - Emirati Arabi Uniti 11
CZ - Repubblica Ceca 11
JO - Giordania 11
EU - Europa 9
PE - Perù 9
PT - Portogallo 9
TW - Taiwan 9
DZ - Algeria 8
IL - Israele 8
NP - Nepal 8
AU - Australia 7
GR - Grecia 7
OM - Oman 7
SY - Repubblica araba siriana 7
TN - Tunisia 7
UY - Uruguay 7
KZ - Kazakistan 6
RO - Romania 6
BO - Bolivia 5
CR - Costa Rica 5
HU - Ungheria 5
LB - Libano 5
LV - Lettonia 5
SK - Slovacchia (Repubblica Slovacca) 5
TH - Thailandia 5
AZ - Azerbaigian 4
BG - Bulgaria 4
CI - Costa d'Avorio 4
DO - Repubblica Dominicana 4
HN - Honduras 4
KG - Kirghizistan 4
LY - Libia 4
PS - Palestinian Territory 4
AL - Albania 3
BZ - Belize 3
CY - Cipro 3
MU - Mauritius 3
NI - Nicaragua 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PA - Panama 3
RS - Serbia 3
TT - Trinidad e Tobago 3
BH - Bahrain 2
EE - Estonia 2
GA - Gabon 2
GE - Georgia 2
GT - Guatemala 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
Totale 24.065
Città #
Ann Arbor 1.609
Singapore 1.177
Ashburn 1.064
Woodbridge 679
San Jose 669
Hong Kong 628
Chandler 545
Milan 522
Frankfurt am Main 520
Houston 505
Fairfield 392
Dublin 383
Jacksonville 349
Wilmington 323
New York 308
Toronto 306
Ho Chi Minh City 278
Dearborn 263
Santa Clara 262
Dallas 257
Hanoi 210
Los Angeles 210
Beijing 187
Seattle 173
Princeton 152
Chicago 138
Cambridge 137
Vienna 129
The Dalles 117
Shanghai 111
Hefei 107
Rome 97
Nanjing 96
Boardman 93
Seoul 87
Lauterbourg 78
Buffalo 74
Council Bluffs 73
São Paulo 70
Helsinki 69
Lachine 61
Moscow 57
Altamura 54
Munich 54
Guangzhou 52
Da Nang 50
Jakarta 47
Lawrence 47
London 45
Orem 45
Kraków 44
Brussels 41
Chennai 38
Columbus 37
Tokyo 37
Fremont 36
Haiphong 35
Turin 34
Changsha 33
Shenyang 33
Pisa 32
Montreal 31
Warsaw 29
Nanchang 28
San Diego 28
Turku 28
Atlanta 27
Jinan 27
Tianjin 27
Dong Ket 26
Phoenix 26
San Francisco 25
Andover 24
Baghdad 24
Denver 24
Pune 24
Rio de Janeiro 24
Zhengzhou 23
Amsterdam 22
Biên Hòa 22
Brooklyn 22
Falls Church 22
Hebei 22
Piscataway 22
Grafing 21
Lahore 21
Monza 21
Ottawa 21
Zurich 21
New Delhi 20
North Bergen 20
Poplar 20
Belo Horizonte 19
Jiaxing 19
Johannesburg 19
Lecco 19
Manchester 19
Secaucus 19
Newark 18
Stockholm 18
Totale 15.251
Nome #
ALS Cognitive Behavioral Screen (ALS-CBS): normative values for the Italian population and clinical usability 651
NMR-driven identification of anti-amyloidogenic compounds in green and roasted coffee extracts 538
Rotenone down-regulates HSPA8/hsc70 chaperone protein in vitro: A new possible toxic mechanism contributing to Parkinson's disease 496
Serum naturally occurring anti-TDP-43 auto-antibodies are increased in amyotrophic lateral sclerosis 457
Oxidative stress and altered mitochondrial dynamics in neurodegenerative processes 432
Ischemic Conditions Affect Rerouting of Tau Protein Levels: Evidences for Alteration in Tau Processing and Secretion in Hippocampal Neurons 411
NMR-based Lavado cocoa chemical characterization and comparison with fermented cocoa varieties: Insights on cocoa's anti-amyloidogenic activity 391
Digested Cinnamon (Cinnamomum verum J. Presl) Bark Extract Modulates Claudin-2 Gene Expression and Protein Levels under TNFα/IL-1β Inflammatory Stimulus 373
Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (Nature Communications, (2021), 12, 1, (3417), 10.1038/s41467-021-22491-8) 371
Rotenone upregulates alpha-synuclein and myocyte enhancer factor 2D independently from lysosomal degradation inhibition 368
A panel of macroautophagy markers in lymphomonocytes of patients with amyotrophic lateral sclerosis 366
HSC70 expression is reduced in lymphomonocytes of sporadic ALS patients and contributes to TDP-43 accumulation 365
Increased susceptibility to plasma lipid peroxidation in Alzheimer disease patients 362
Peripheral cytokine release in Alzheimer patients: Correlation with disease severity 356
Riluzole Selective Antioxidant Effects in Cell Models Expressing Amyotrophic Lateral Sclerosis Endophenotypes 354
MEF2D and MEF2C pathways disruption in sporadic and familial ALS patients 348
Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer's disease 346
Study of alpha-synuclein and its catabolic pathways in ex vivo cells of patients with Parkinson’s disease 335
In vitro study of autophagy dysfunctions associated with Parkinson’s disease 331
NMR-driven identification of cinnamon bud and bark components with anti-Aβ activity 330
Reduced platelet glutamate uptake in Parkinson's disease 328
Reduced expression of the chaperone-mediated autophagy carrier hsc70 protein in lymphomonocytes of patients with Parkinson's disease 326
TSPO Modulates Oligomeric Amyloid-β-Induced Monocyte Chemotaxis: Relevance for Neuroinflammation in Alzheimer's Disease 323
Rotenone down-regulates hspa8/hsc70 protein in vitro: a new possible toxic mechanism contributing to Parkinson’s disease 318
Rotenone-induced down-regulation of HSPA8/hsc70 protein increases alphasynuclein in vitro: possible implications for Parkinson’s disease 315
Riluzole display glutamate-independent antioxidant properties: relevance for ALS 312
Study Of Chaperone Mediated Autophagy in Lymphomonocytes of sporadic and familial als patients evidenced Hsc70 reduction and TDP-43 aggregation 311
New insights into the genetic etiology of Alzheimer's disease and related dementias 308
Alzheimer's Disease Prevention through Natural Compounds: Cell-Free, In Vitro, and In Vivo Dissection of Hop (Humulus lupulus L.) Multitarget Activity 306
Effect of mitochondrial complex I inhibition on chaperone-mediated and myocyte enhancer factor 2D in human neuroblastoma cells 306
A Preliminary Study of Chaperone-Mediated Autophagy in ALS Lymphomonocytes 305
Leber hereditary optic neuropathy mtDNA mutations disrupt glutamate transport in cybrid cell lines 297
Multi-pathway blood biomarkers to target and monitor multidimensional prevention of cognitive and functional decline (nested in the IN-TeMPO study framed within the world-wide FINGERS network) 295
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores 295
Study of alpha-synuclein and its catabolic pathways in lymphomonocytes of patients with Parkinson's disease 291
Pravastatin acute neuroprotective effects depend on blood brain barrier integrity in experimental cerebral ischemia 288
Nerve growth factor and transforming growth factor-β serum levels in acute stroke patients: Possible involvement of neurotrophins in cerebrovascular disease 286
Decreased platelet glutamate uptake and genetic risk factors in patients with Parkinson's disease 286
Exploring the role of autophagy in the pathogenesis of rotenone-induced toxicity 285
Myocyte Enhacer Factor 2 Pathway Disruption in Lymphomonocytes of Patients with Sporadic and Familial Form of Amyotrophic Lateral Sclerosis 284
Role of chaperone-mediated autophagy dysfunctions in the pathogenesis of Parkinson’s disease 284
Ischemic injury elicits the unconventional secretion of protein hallmarks of Alzheimer's disease onset as seeds for interneuronal propagation 283
Impairment of glutamate transport and increased vulnerability to oxidative stress in neuroblastoma SH-SY5Y cells expressing a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis 282
Reduced expression of hsc70 protein in lymphomonocytes of patients with Parkinson's disease 281
Core blood biomarkers of Alzheimer's disease: A single-center real-world performance study 279
Valproate and HDAC inhibition: A new epigenetic strategy to mitigate phenotypic severity in ALS? 277
Alpha-Synuclein, Oxidative Stress and Autophagy Failure: Dangerous Liaisons in Dopaminergic Neurodegeneration 274
Platelet glutamate uptake as peripheral marker of excitotoxicity in neurodegenerative disorders 272
Mef2d-mef2c pathways are altered in lymphomonocytes of patients with sporadic and familial form of amyotrophic lateral sclerosis 271
Assessment of chaperone-mediated autophagy in circulating lymphomonocytes of patients with Parkinson disease 269
Mitochondrial dysfunction due to mutant copper/zinc superoxide dismutase associated with amyotrophic lateral sclerosis is reversed by N-acetylcysteine 267
MEF2D and MEF2C Pathways Disruption in Sporadic and Familial ALS Patients 259
Acute lipophilicity-dependent effect of intravascular simvastatin in the early phase of focal cerebral ischemia 256
AUTOPHAGY ALTERATION UNDER ISCHEMIC CONDITION: A POSSIBLE LINK TO ALZHEIMER'S DISEASE 256
Lack of evidence for oxidative stress in sporadic amyotrophic lateral sclerosis fibroblasts 254
Direct current stimulation enhances neuronal alpha-synuclein degradation in vitro 253
Huntington's disease and HDACi: Would sulpiride and valproate be of therapeutic value? 252
the MonzALS collaborative network 250
MEF2C and MEF2D alterations in sporadic and familial ALS patients: a possible correlation with disease progression? 249
Vesicular monoamine transporter 2 mRNA levels are reduced in platelets from patients with Parkinson's disease 246
Myocyte Enhacer Factor 2 Pathway Disruption in Lymphomonocytes of Patients with Sporadic and Familial Form of Amyotrophic Lateral Sclerosis 246
Myocyte enhancer factor-2D expression in ALS lymphomonocytes 241
HSPA8 knock-down induces the accumulation of neurodegenerative disorder-associated proteins 237
Inhibition of retrograde transport modulates misfolded protein accumulation and clearance in motoneuron diseases 236
Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation 235
Macroautophagy is not altered in ALS lymphomonocytes 220
Chaperone mediated autophagy in Parkinson's disease: Study in peripheral blood cells from patients and in a cellular model 220
Partial mitochondrial complex I inhibition induces oxidative damage and perturbs glutamate transport in primary retinal cultures. Relevance to Leber Hereditary Optic Neuropathy (LHON) 218
Decreased platelet glutamate uptake in patients with amyotrophic lateral sclerosis 218
Dysfunction of chaperone-mediated autophagy in lymphomonocytes from patients with Parkinson's disease and in a cellular model 218
Analysis of glutamate transporters in peripheral cells: A tool to invistigate excitotoxicity in neurodegenerative disorders 208
Myocyte Enhacer Factor-2 Pathway Is Altered In Amyotrophic Lateral Sclerosis Peripheral Blood Mononuclear Cells 201
Increased interleukin-6 release from peripheral blood cells of patients after brain trauma 193
Interactions between excitotoxicity and oxidative stress in ALS: clues for pharmacotherapy 189
Assessing glutamatergic function and dysfunction in peripheral tissues 189
Antioxidants partially restore glutamate transport defect in leber hereditary optic neuropathy cybrids 183
Valproate Treatment in an ALS Patient Carrying a c.194G>A Spastin Mutation and SMN2 Homozygous Deletion 179
Whole-blood global DNA methylation and phenotypic variability in ALS 176
Recent advances in the therapy of amyotrophic lateral sclerosis: Focus on excitotoxicity 174
Multicomponent interventions and technologies to reduce the burden of frailty, functional, and cognitive decline: insights from the Age-It Research Program 172
Whole-blood global DNA methylation is increased in amyotrophic lateral sclerosis independently of age of onset 172
ALS genocopy due to co-existence of spastin mutation and SMN2 deletion? A 12 months open label trial with valproic acid 166
Author Correction: Direct current stimulation enhances neuronal alpha-synuclein degradation in vitro (Scientific Reports, (2021), 11, 1, (2197), 10.1038/s41598-021-81693-8) 162
Neuroprotection and Non-Invasive Brain Stimulation: Facts or Fiction? 157
Platelets 136
Multicenter Translational Trial of Remote Ischemic Conditioning in Acute Ischemic Stroke (TRICS BASIC) 106
Iatrogenic Cerebral Amyloid Angiopathy-Related Inflammation: A Multicenter Case Series 94
Effects of multidomain interventions on health outcomes in older adults: A systematic review and meta-analysis 25
NMR-based metabolic profiling of human plasma for the identification of biomarkers associated with ageing 16
Totale 24.547
Categoria #
all - tutte 73.150
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.150


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021143 0 0 0 0 0 0 0 0 0 0 0 143
2021/20221.120 97 126 109 100 81 113 45 57 50 69 108 165
2022/20232.119 190 615 193 239 163 321 26 117 144 17 50 44
2023/20241.674 81 79 104 88 201 456 239 90 79 14 31 212
2024/20253.377 170 407 276 135 253 185 161 139 318 549 278 506
2025/20269.557 1.107 571 689 934 1.000 463 1.474 403 908 893 566 549
Totale 24.547